Lung mass medical therapy

Lung Mass Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Causes
Differentiating Lung Mass from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Diagnosis
Diagnostic Study of Choice
Evaluation of Lung Mass
Imaging of Lung Mass
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Lung mass medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Lung mass medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Lung mass medical therapy
CDC on Lung mass medical therapy
Lung mass medical therapy in the news
Blogs on Lung mass medical therapy
Directions to Hospitals Treating bone or soft tissue mass
Risk calculators and risk factors for Lung mass medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief:

Medical Therapy

Medical therapy for patients with lung mass vary and depends upon the underlying histology and staging.

• Patients with Small Cell Carcinoma are treated with chemotherapy. Small cell carcinoma generally present at an advanced stage where surgery is not advisable and hence treated with chemotherapy.
• Patients with Non-Small Cell Carcinoma (NSCC), are treated with surgical resection whenever surgery is advisable.